These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

526 related items for PubMed ID: 9833852

  • 1. Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study.
    Bisset LR, Cone RW, Huber W, Battegay M, Vernazza PL, Weber R, Grob PJ, Opravil M.
    AIDS; 1998 Nov 12; 12(16):2115-23. PubMed ID: 9833852
    [Abstract] [Full Text] [Related]

  • 2. Long-term evaluation of T-cell subset changes after effective combination antiretroviral therapy during asymptomatic HIV-infection.
    Bisset LR, Cone RW, Fischer M, Battegay M, Vernazza PL, Dubs RW, Weber R, Grob PJ, Opravil M, Swiss HIV Cohort Study.
    J Acquir Immune Defic Syndr; 2001 Jul 01; 27(3):266-71. PubMed ID: 11464146
    [Abstract] [Full Text] [Related]

  • 3. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
    Plana M, García F, Gallart T, Tortajada C, Soriano A, Palou E, Maleno MJ, Barceló JJ, Vidal C, Cruceta A, Miró JM, Gatell JM.
    AIDS; 2000 Sep 08; 14(13):1921-33. PubMed ID: 10997396
    [Abstract] [Full Text] [Related]

  • 4. Phenotypic analysis of CD8+ T lymphocytes in a cohort of HIV type 1-infected patients treated with saquinavir, ritonavir, and two nucleoside analogs for 1 year, and association with plasma HIV type 1 RNA.
    Kaufmann GR, Zaunders JJ, Cunningham P, Cooper DA.
    AIDS Res Hum Retroviruses; 1999 Jul 20; 15(11):963-72. PubMed ID: 10445808
    [Abstract] [Full Text] [Related]

  • 5. Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection.
    Dyrhol-Riise AM, Voltersvik P, Olofsson J, Asjö B.
    AIDS; 1999 Dec 03; 13(17):2365-76. PubMed ID: 10597778
    [Abstract] [Full Text] [Related]

  • 6. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
    Gray CM, Schapiro JM, Winters MA, Merigan TC.
    AIDS Res Hum Retroviruses; 1998 May 01; 14(7):561-9. PubMed ID: 9591710
    [Abstract] [Full Text] [Related]

  • 7. Impact of suppression of viral replication by highly active antiretroviral therapy on immune function and phenotype in chronic HIV-1 infection.
    Lange CG, Lederman MM, Madero JS, Medvik K, Asaad R, Pacheko C, Carranza C, Valdez H.
    J Acquir Immune Defic Syndr; 2002 May 01; 30(1):33-40. PubMed ID: 12048361
    [Abstract] [Full Text] [Related]

  • 8. Naïve and memory CD4+ T cells and T cell activation markers in HIV-1 infected children on HAART.
    Resino S, Navarro J, Bellón JM, Gurbindo D, León JA, Muñoz-Fernández MA.
    Clin Exp Immunol; 2001 Aug 01; 125(2):266-73. PubMed ID: 11529919
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection.
    Kestens L, Vanham G, Vereecken C, Vandenbruaene M, Vercauteren G, Colebunders RL, Gigase PL.
    Clin Exp Immunol; 1994 Mar 01; 95(3):436-41. PubMed ID: 7907956
    [Abstract] [Full Text] [Related]

  • 13. Association of CD8+ T lymphocyte subsets with the most commonly used markers to monitor HIV type 1 infection in children treated with highly active antiretroviral therapy.
    Navarro J, Resino S, Bellón JM, Abad ML, Gurbindo D, Fernández-Cruz E, Muñóz-Fernández MA.
    AIDS Res Hum Retroviruses; 2001 Apr 10; 17(6):525-32. PubMed ID: 11350666
    [Abstract] [Full Text] [Related]

  • 14. Parallel decline of CD8+/CD38++ T cells and viraemia in response to quadruple highly active antiretroviral therapy in primary HIV infection.
    Tilling R, Kinloch S, Goh LE, Cooper D, Perrin L, Lampe F, Zaunders J, Hoen B, Tsoukas C, Andersson J, Janossy G, Quest Study Group.
    AIDS; 2002 Mar 08; 16(4):589-96. PubMed ID: 11873002
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The dominant source of CD4+ and CD8+ T-cell activation in HIV infection is antigenic stimulation.
    Cohen Stuart JW, Hazebergh MD, Hamann D, Otto SA, Borleffs JC, Miedema F, Boucher CA, de Boer RJ.
    J Acquir Immune Defic Syndr; 2000 Nov 01; 25(3):203-11. PubMed ID: 11115950
    [Abstract] [Full Text] [Related]

  • 17. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART).
    Hazenberg MD, Stuart JW, Otto SA, Borleffs JC, Boucher CA, de Boer RJ, Miedema F, Hamann D.
    Blood; 2000 Jan 01; 95(1):249-55. PubMed ID: 10607709
    [Abstract] [Full Text] [Related]

  • 18. Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy.
    Benito JM, López M, Lozano S, Ballesteros C, Martinez P, González-Lahoz J, Soriano V.
    J Acquir Immune Defic Syndr; 2005 Apr 01; 38(4):373-81. PubMed ID: 15764953
    [Abstract] [Full Text] [Related]

  • 19. Increased HLA-DR expression on peripheral blood monocytes in subsets of subjects with primary HIV infection is associated with elevated CD4 T-cell apoptosis and CD4 T-cell depletion.
    Gascon RL, Narváez AB, Zhang R, Kahn JO, Hecht FM, Herndier BG, McGrath MS.
    J Acquir Immune Defic Syndr; 2002 Jun 01; 30(2):146-53. PubMed ID: 12045676
    [Abstract] [Full Text] [Related]

  • 20. Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients.
    Bofill M, Mocroft A, Lipman M, Medina E, Borthwick NJ, Sabin CA, Timms A, Winter M, Baptista L, Johnson MA, Lee CA, Phillips AN, Janossy G.
    AIDS; 1996 Jul 01; 10(8):827-34. PubMed ID: 8828739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.